Immediate Impact
9 standout
Citing Papers
Therapeutic effect of bosentan on 2, 4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis mouse model
2025 Standout
Atopic dermatitis
2025 Standout
Works of Robert Higham being referenced
639 - Efficacy and safety of once-daily roflumilast cream 0.05% in pediatric patients 2 to 5 years of age with mild to moderate atopic dermatitis (INTEGUMENT-PED): a phase 3 randomized controlled trial
2024
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert Higham | 62 | 61 | 18 | 28 | 31 | 108 | |
| Ezgi Özkur | 103 | 61 | 8 | 22 | 34 | 186 | |
| Henner Zirpel | 44 | 63 | 18 | 31 | 24 | 168 | |
| Niccolò Siliquini | 151 | 114 | 59 | 20 | 17 | 186 | |
| Maria Polina Konstantinou | 102 | 42 | 22 | 13 | 25 | 180 | |
| Suvi‐Päivikki Sinikumpu | 110 | 16 | 28 | 20 | 39 | 215 | |
| Ali Al‐Janabi | 120 | 92 | 29 | 50 | 16 | 186 | |
| Algün Polat Ekinci | 68 | 51 | 20 | 23 | 32 | 140 | |
| Lorne Albrecht | 96 | 90 | 33 | 19 | 16 | 154 | |
| Megan Mosca | 105 | 163 | 27 | 32 | 21 | 215 | |
| Maria C. Schneeweiss | 98 | 42 | 27 | 31 | 21 | 177 |
All Works
Loading papers...